Inventor

MITSUYA HIROAKI

US39 patents

⚠️ This page may combine multiple inventors who share the name “MITSUYA HIROAKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MITSUYA HIROAKI

US HEALTH

Treatment of human retroviral infections with 2&#39;,3&#39;-dideoxyinosine alone and in combination with other antiviral compounds

Antiviral compositions and methods

Antiviral compositions and methods

2&#39;,3&#39;-dideoxy-2&#39;-fluoro-purine nucleosides and methods for using same

Lipophilic, aminohydrolase-activated prodrugs

Fitness assay and associated methods

Method of treating HIV with 2&#39;,3&#39;-dideoxyinosine

Treatment of retroviral induced dementia by administration of 2&#39;,3&#39;-dideoxyinosine

Immortalized T-lymphocyte cell line for testing HTLV-III inactivation

Method of inhibiting HIV replication with 2&#39;,3&#39;-dideoxyadenosine

Pyrimidine and purine 1,2-butadiene-4-ols as anti-retroviral agents

Acid stable purine dideoxynucleosides

Fitness assay and associated methods

PURDUE RESEARCH FOUNDATION

HIV-1 protease inhibitors and uses thereof

Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS

Tricyclic P2-ligand containing potent HIV-protease inhibitors against HIV/AIDS

HIV-1 protease inhibitors having gem-di-fluoro bicyclic P2-ligands

HIV-1 protease inhibitors and uses thereof

Compounds for the treatment of SARS

Compounds and methods for treating HIV

Compunds and methods for treating HIV

Fused tricyclic ether carbamates and their use

Macrocyclic HIV-1 protease inhibitors and uses thereof

HIV-1 protease inhibitors and uses thereof

YAMASA CORP

4′-C-substituted-2-haloadenosine derivative

4′-C-ethynyl pyrimidine nucleosides and pharmaceutical compositions thereof

4′-c-substituted-2-haloadenosine derivative

4′-C-ethynyl purine nucleoside compounds

4′-C-ethynyl pyrimidine nucleoside compounds and pharmaceutical compositions

GHOSH ARUN K

Methods and compositions for treating HIV infections

Fused tricyclic ether carbamates and their use

C-3 substituted bicyclooctane based HIV protease inhibitors

CCR5 antagonists for treating HIV

NAT CENTER FOR GLOBAL HEALTH AND MEDICINE

Compound having biological activity such as antiviral activity

Nucleoside derivative having physiological activity such as antiviral activity

HOFFMANN LA ROCHE

Anti-retroviral compounds

ONO PHARMACEUTICAL CO

Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient

ERICKSON JOHN W

Method of treating HIV infection

SANYO KOKUSAKU PULP CO

Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2&#39;,3&#39;-dideoxyribofuranoxside

Treatment of human retroviral infections with 2',3'-dideoxyinosine alone and in combination with other antiviral compounds

2',3'-dideoxy-2'-fluoro-purine nucleosides and methods for using same

Method of treating HIV with 2',3'-dideoxyinosine

Treatment of retroviral induced dementia by administration of 2',3'-dideoxyinosine

Method of inhibiting HIV replication with 2',3'-dideoxyadenosine

Pharmaceutical composition containing 2-amino-6-chloropurine-9-β-D-2',3'-dideoxyribofuranoxside